tetano
Editor, Senior Moderator
Infection
. 2020 Jul 28.
doi: 10.1007/s15010-020-01483-8. Online ahead of print.
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature
Alessandra Oliva[SUP] 1 [/SUP], G Siccardi[SUP] 2 [/SUP], A Migliarini[SUP] 3 [/SUP], F Cancelli[SUP] 2 [/SUP], M Carnevalini[SUP] 2 [/SUP], M D'Andria[SUP] 4 [/SUP], I Attilia[SUP] 3 [/SUP], V C Danese[SUP] 4 [/SUP], V Cecchetti[SUP] 4 [/SUP], R Romiti[SUP] 4 [/SUP], G Ceccarelli[SUP] 2 [/SUP], C M Mastroianni[SUP] 2 [/SUP], P Palange[SUP] 2 [/SUP], M Venditti[SUP] 2 [/SUP]
Affiliations
Abstract
Introduction: The novel coronavirus SARS-CoV-2 has spread all over the world causing a global pandemic and representing a great medical challenge. Nowadays, there is limited knowledge on the rate of co-infections with other respiratory pathogens, with viral co-infection being the most representative agents. Co-infection with Mycoplasma pneumoniae has been described both in adults and pediatrics whereas only two cases of Chlamydia pneumoniae have been reported in a large US study so far.
Methods: In the present report, we describe a series of seven patients where co-infection with C. pneumoniae (n = 5) or M. pneumoniae (n = 2) and SARS-CoV-2 was detected in a large teaching hospital in Rome.
Results and conclusion: An extensive review of the updated literature regarding the co-infection between SARS-CoV-2 and these atypical pathogens is also performed.
Keywords: COVID-19; Chlamydia pneumoniae; Co-infection; Mycoplasma pneumoniae; SARS-CoV-2 infection.
. 2020 Jul 28.
doi: 10.1007/s15010-020-01483-8. Online ahead of print.
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature
Alessandra Oliva[SUP] 1 [/SUP], G Siccardi[SUP] 2 [/SUP], A Migliarini[SUP] 3 [/SUP], F Cancelli[SUP] 2 [/SUP], M Carnevalini[SUP] 2 [/SUP], M D'Andria[SUP] 4 [/SUP], I Attilia[SUP] 3 [/SUP], V C Danese[SUP] 4 [/SUP], V Cecchetti[SUP] 4 [/SUP], R Romiti[SUP] 4 [/SUP], G Ceccarelli[SUP] 2 [/SUP], C M Mastroianni[SUP] 2 [/SUP], P Palange[SUP] 2 [/SUP], M Venditti[SUP] 2 [/SUP]
Affiliations
- PMID: 32725598
- DOI: 10.1007/s15010-020-01483-8
Abstract
Introduction: The novel coronavirus SARS-CoV-2 has spread all over the world causing a global pandemic and representing a great medical challenge. Nowadays, there is limited knowledge on the rate of co-infections with other respiratory pathogens, with viral co-infection being the most representative agents. Co-infection with Mycoplasma pneumoniae has been described both in adults and pediatrics whereas only two cases of Chlamydia pneumoniae have been reported in a large US study so far.
Methods: In the present report, we describe a series of seven patients where co-infection with C. pneumoniae (n = 5) or M. pneumoniae (n = 2) and SARS-CoV-2 was detected in a large teaching hospital in Rome.
Results and conclusion: An extensive review of the updated literature regarding the co-infection between SARS-CoV-2 and these atypical pathogens is also performed.
Keywords: COVID-19; Chlamydia pneumoniae; Co-infection; Mycoplasma pneumoniae; SARS-CoV-2 infection.